Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2003
10/23/2003WO2003086293A2 Pharmaceutical preparation for taste masking
10/23/2003WO2003086290A2 Electroprocessing of materials useful in drug delivery and cell encapsulation
10/23/2003WO2003086267A2 Multi-phase, multi-compartment capsular system
10/23/2003WO2003086104A1 Encapsulated agglomeration of microcapsules and method for the preparation thereof
10/23/2003WO2003086097A1 Composition for modulating a physiological reaction or inducing an immune response
10/23/2003WO2003086041A2 Binding agents and their use in targeting tumor cells
10/23/2003WO2003059250A3 Compositions and methods for treating female sexual arousal disorder using hydrophobic-calcitonin gene related peptide
10/23/2003WO2003053479A3 Composition for treating contact lenses
10/23/2003WO2003053325A3 Microencapsulation of drugs by solvent exchange
10/23/2003WO2003047522A3 Composition and method for decreasing upper respiratory airway resistance
10/23/2003WO2003041656A3 Soluble drug extended release system
10/23/2003WO2003028698A3 Method and device for producing granulates that comprise at least one pharmaceutical active substance
10/23/2003WO2003015779A3 Matrix controlled transdermal therapeutic system for the use of pramipexole and ropinirole
10/23/2003WO2003013421A3 Pharmaceutical composition comprising a water/oil/water double microemulsion incorporated in a solid support
10/23/2003WO2003000226A3 Pharmaceutical compositions containing polymer and drug assemblies
10/23/2003WO2002094248A3 Composition and use of substances for stabilising amino acids containing sulphur and/or for inhibiting the continuous formation of amino acids containing sulphur in a blood sample
10/23/2003WO2002092056A8 Compaction process for manufacture of sodium phenytoin dosage form
10/23/2003WO2002074034A3 Novel medicament compositions based on anticholinergic agents and endothelin antagonists
10/23/2003WO2002072687A3 Physical forms of clarified hydrocolloids of undiminished properties and method of producing same
10/23/2003WO2002044336B1 Method of making a protein polymer and uses of the polymer
10/23/2003WO2002044321A3 Rna interference mediating small rna molecules
10/23/2003WO2002036145A8 Kahalalide f formulation
10/23/2003WO2001047562A8 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
10/23/2003WO2001010481A8 Drug dispensing system
10/23/2003US20030199855 Implantable infusion device with optimized peristaltic pump motor drive
10/23/2003US20030199854 Generic multi-step therapeutic treatment protocol
10/23/2003US20030199809 Methods, systems, and kits for implanting articles
10/23/2003US20030199624 Conductive nanocomposite films
10/23/2003US20030199615 A water based thermosensitive self-gelling liquid comprising cationic polymer and a phosphates, free of insoluble particles, injectable thermo-setting slurry; injectable Bone Substitutes for repairing
10/23/2003US20030199594 Helium propellant composition for use with aerosols
10/23/2003US20030199588 Levothyroxine compositions and methods
10/23/2003US20030199586 Comprises crosslinked sodium carboxymethylcellulose; hormone replacement therapy
10/23/2003US20030199585 Immediate release thyroid hormone drugs; sugar-free
10/23/2003US20030199582 Tolterodine salts
10/23/2003US20030199538 Imidazoquinoline amines, imidazotetrahydroquinoline amines, imidazopyridine amines and other amines containing heterocyclic rings, a fatty acid and a hydrophobic, aprotic component miscible with fatty acid; useful for skin disorders
10/23/2003US20030199498 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
10/23/2003US20030199485 Novel anti-inflammatory androstane derivative
10/23/2003US20030199484 Method for the treatment of urinary incontinence
10/23/2003US20030199481 Pharmaceutical compositions of acetylsalicylic acid and omega-3 oils
10/23/2003US20030199480 Modified release preparation
10/23/2003US20030199477 Use of gellable pharmaceutical compositions in periodontology
10/23/2003US20030199476 Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof
10/23/2003US20030199449 Combination of ablation and controlled drug delivery for the treatment of cancer
10/23/2003US20030199433 Pharmaceutical composition
10/23/2003US20030199426 Combination of a saturated or unsaturated fatty alcohol or fatty acid; a C1/C4 alkanol; a polyalcohol in particular propylenglycol; water; and optionally a monoalkylether of diethylene glycol as a permeation enhancer
10/23/2003US20030199425 Administering a drug that inhibits proliferation and cell migration, and a biocompatible protein; reduced toxicity.
10/23/2003US20030198693 Filling, closing capsules; detecting concentration, calibration
10/23/2003US20030198683 Controlled release oral dosage form
10/23/2003US20030198682 Encapsulation cosmetic in water soluble polysaccharides; topical applying to human skins
10/23/2003US20030198681 Method of making a protein polymer and uses of the polymer
10/23/2003US20030198680 Solid, free-flowing powder; solid hydrophobic nanostructure; moisture trigger release
10/23/2003US20030198679 Flocculated pharmaceutical suspensions and methods for actives
10/23/2003US20030198678 Polynucleotide immobilized with block polyether polymer; antibodies against genetic disorders
10/23/2003US20030198677 Concentration gradient of active materials; compression; drug delivery
10/23/2003US20030198676 Sustained-release preparation for AII antagonist, production and use thereof
10/23/2003US20030198675 Method of providing sustained analgesia with buprenorphine
10/23/2003US20030198674 Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor
10/23/2003US20030198673 Water insoluble acrylic polymer and ethyl cellulose; protective coatings; storage stability
10/23/2003US20030198672 Levothyroxine mixed with cellulose; immediate release solid dosage form; dietetics; glandular disorders; cardiovascular disorders
10/23/2003US20030198671 Levothyroxine mixed with cellulose; immediate release solid dosage form; dietetics; glandular disorders; cardiovascular disorders
10/23/2003US20030198670 Albuterol sulfate core and overcoatings
10/23/2003US20030198669 Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
10/23/2003US20030198668 Levothyroxine pharmaceutical compositions, methods of making and methods of administration
10/23/2003US20030198667 Methods of producing dispersible pharmaceutical compositions
10/23/2003US20030198666 Side effect reduction; using mixture of insulin and adjuvant
10/23/2003US20030198665 Attaching drug to hydrophilic polymer
10/23/2003US20030198664 Encapsulation drug; screening active materials
10/23/2003US20030198663 Phospholipid-analogous compounds
10/23/2003US20030198662 Central nervous system disorders; psychological disorders
10/23/2003US20030198658 Mixture of diketopiperazine and active materials; administering by mouth
10/23/2003US20030198656 N-acetylamino acids, related N-acetyl compounds and their topical use
10/23/2003US20030198652 Multi component controlled release system for anhydrous cosmetic compositons
10/23/2003US20030198630 Mixture of carbohydrates, amino acid, electrolyte and chondroitin sulfate; refraction eye surgery
10/23/2003US20030198619 Mixture containing permeability intensifier; in situ gelation using nonionic surfactant
10/23/2003US20030198602 Improved absorption; drug delivery
10/23/2003US20030198601 Dry powder drug; aerosol administering
10/23/2003US20030198600 Mixture of drug, propellant and cosolvent; breathing device
10/23/2003US20030196599 Apparatus for clamping a planar substrate
10/23/2003CA2849556A1 Preservation of bioactive materials by freeze dried foam
10/23/2003CA2482646A1 Method of stabilizing bupropion hydrochloride tablets
10/23/2003CA2482448A1 Preservation of bioactive materials by freeze dried foam
10/23/2003CA2482263A1 Therapeutic dry powder preparation
10/23/2003CA2482225A1 Targeted controlled delivery compositions activated by changes in ph or salt concentration
10/23/2003CA2482216A1 Patch and process for producing the same
10/23/2003CA2482086A1 Polymeric fibre and method for making same
10/23/2003CA2481796A1 Binding agents and their use in targeting tumor cells
10/23/2003CA2481784A1 Methods for lightening skin and hair
10/23/2003CA2481752A1 Composition for modulating a physiological reaction or inducing an immune response
10/23/2003CA2481683A1 Ansamycin formulations and methods for producing and using same
10/23/2003CA2481677A1 Process for preparing a finely self-emulsifiable pharmaceutical composition
10/23/2003CA2481667A1 Sustained release pharmaceutical prepartations and methods for producing the same
10/23/2003CA2481595A1 Solid dispersion composition
10/23/2003CA2481384A1 Aqueous dispersible steryl ester compositions
10/23/2003CA2481372A1 Method to inhibit cell growth using oligonucleotides
10/23/2003CA2481370A1 Process for preparing tannate liquid and semi-solid dosage forms
10/23/2003CA2481187A1 Formoterol and ciclesonide aerosol formulations
10/23/2003CA2481139A1 New film coating
10/23/2003CA2481092A1 Low dose liquid entecavir formulations and use
10/23/2003CA2481091A1 Sustained release metoprolol formulations
10/23/2003CA2480882A1 Low-dose potassium supplementation for the prevention and treatment of hypertension
1 ... 2077 2078 2079 2080 2081 2082 2083 2084 2085 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 ... 2991